• Shopping cart is empty.

    The International Society for Aerosols in Medicine

    Journal

    The Official Journal of the International Society for Aerosols in Medicine

    Aim and Scope

    The Journal of Aerosol Medicine and Pulmonary Drug Delivery is the only peer-reviewed journal delivering innovative, authoritative coverage of the health effects of inhaled aerosols and delivery of drugs through the pulmonary system. The Journal is a forum for leading experts, addressing novel topics such as aerosolized chemotherapy, aerosolized vaccines, methods to determine toxicities, and delivery of aerosolized drugs in the intubated patient.

    Coverage

    Pulmonary drug delivery

    Airway reactivity and asthma treatment

    Inhalation of particles and gases in the respiratory tract

    Toxic effects of inhaled agents

    Aerosols as tools for studying basic physiologic phenomena

    Journal Impact Factor

    The Journal of Aerosol Medicine and Pulmonary Drug Delivery impact factor increased, when compared to preceding years. The impact factor, also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal.

    Latest Impact Factor (2020) is 2.846

    Editors

    Editor-in-Chief: Gerald C. Smaldone, MD, PhD, Pulmonary, Critical Care and Sleep Division, School of Medicine, State University of New York at Stony Brook

    Associate Editor: Tim Corcoran, PhD, Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh 

    Indexed and Abstracted in

    MEDLINE; PubMed; PubMed Central; Current Contents®/Clinical Medicine; Science Citation Index Expanded; Journal Citation Reports/Science Edition; Prous Science Integrity®; EMBASE/Excerpta Medica; Scopus; ProQuest databases

    Business Comminiciation

    Business communications and advertising inquiries should be addressed to the publisher Mary Ann Liebert, Inc.